Log In
BCIQ
Print this Print this
 

Interleukin-12 (IL-12)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Interleukin-12 (IL-12)

BCIQ
Print ChartPrint this
Marketed, 1 Registration, 1 Phase II, 1 Phase II, 1 Phase II, 2 Phase II, 1 Phase I/II, 4 Phase I, 2 Preclinical, 1 Preclinical, 1 Preclinical, 2 Preclinical, 3 Discovery, 1
Phase of DevelopmentDiscoveryPreclinicalPhase IPhase I/IIPhase IIRegistrationMarketed
Autoimmune

1

3

-

-

1

1

1

Cancer

-

2

2

4

2

-

-

Endocrine / Metabolic

-

1

-

-

-

-

-

Hepatic

-

-

-

-

1

-

-

Inflammation

-

1

-

-

1

-

-




 Products Targeting Interleukin-12 (IL-12)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

9

$120.1M

$36.0M

$730.4M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today